Paper Details

  1. Home
  2. Paper Details

Intraperitoneal carboplatin-based chemotherapy for epithelial ovarian cancer.

Author: ColemanRobert L, FujiwaraKeiichi, MarkmanMaurie, MorganMark

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

This review discusses the current status and future perspectives of intraperitoneal (IP) chemotherapy for ovarian cancer, highlighting its potential benefits in targeting the disease within the peritoneal cavity.
Paper Details　
Original Abstract of the Article :
Intraperitoneal (IP) chemotherapy is an attractive approach to the treatment of ovarian cancer because the disease remains confined to the peritoneal cavity for a large part of its natural history. In this review article, we discuss the current status and future perspectives of IP chemotherapy for o...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.ygyno.2004.12.005

データ提供：米国国立医学図書館（NLM）

Intraperitoneal Chemotherapy for Ovarian Cancer

The field of [oncology] is constantly searching for more effective and less invasive treatments for [cancer]. This study focuses on a specific type of [chemotherapy] called [intraperitoneal chemotherapy] for the treatment of [ovarian cancer]. The authors provide a [comprehensive review] of the current status and future perspectives of this approach, highlighting its potential as a targeted therapy. They argue that delivering [chemotherapy] directly into the [peritoneal cavity] is advantageous because [ovarian cancer] often remains confined to this area during the early stages of the disease. The authors discuss the benefits of [intraperitoneal chemotherapy], including [localized drug delivery] and [potential for higher drug concentrations] in the [peritoneal cavity].

A Promising Treatment Strategy

The research highlights the promise of [intraperitoneal chemotherapy] as a potential treatment strategy for [ovarian cancer]. The [review] suggests that this approach could potentially offer [improved efficacy] and [reduced systemic side effects] compared to traditional [intravenous chemotherapy]. This could significantly improve the quality of life for [ovarian cancer] patients. Imagine a desert oasis; intraperitoneal chemotherapy is like delivering water directly to the thirsty roots of a plant, providing a more targeted and effective solution.

Understanding the Potential Benefits

The study provides valuable information for patients with [ovarian cancer] and their healthcare providers. It highlights the importance of considering [intraperitoneal chemotherapy] as a potential treatment option and encourages [further research] to explore its full potential. By understanding the potential benefits of this approach, patients can make informed decisions about their treatment plan, navigating the challenging landscape of [cancer treatment] with greater confidence and hope.

Dr.Camel's Conclusion

The research provides valuable insights into the potential of intraperitoneal chemotherapy for ovarian cancer. It underscores the need for continued research and innovation in the field of oncology to develop more targeted and effective treatments for cancer.

Date :
  1. Date Completed 2005-06-21
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

15790431

DOI: Digital Object Identifier

10.1016/j.ygyno.2004.12.005

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.